Beyond "favorable": early molecular response and outcomes in pediatric RUNX1::RUNX1T1 AML
Access Restricted
Access to this document is restricted. Some items have been embargoed at the request of the author, but will be made publicly available after the "No Access Until" date.
During the embargo period, you may request access to the item by clicking the link to the restricted file(s) and completing the request form. If we have contact information for a Cornell author, we will contact the author and request permission to provide access. If we do not have contact information for a Cornell author, or the author denies or does not respond to our inquiry, we will not be able to provide access. For more information, review our policies for restricted content.
File(s)
No Access Until
2026-10-24
Permanent Link(s)
Author
Gilligan, M.
Gomez-Arteaga, A.
Journal / Series
Leukemia & lymphoma
Volume & Issue
66(13)
Date Issued
2025-10-24
Publisher
Taylor and Francis
Keywords
Previously Published as
Gilligan M, Gomez-Arteaga A. Beyond "favorable": early molecular response and outcomes in pediatric RUNX1::RUNX1T1 AML. Leukemia & lymphoma. 2025;66(13):2562-2566. doi: 10.1080/10428194.2025.2576559. PMID: 41133466.
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International
Type
article